生命科学资讯

Gilead brings Arcellx fully under the fold

Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy

Gilead to acquire cell therapy partner Arcellx for $7.8B

All about cell therapy process characterization

Structure of the lysosomal KICSTOR-GATOR1-SAMTOR nutrient-sensing supercomplex

Symbiotic entrenchment through ecological Catch-22

Unified modeling of 3D molecular generation via atomic interactions with PocketXMol

A circadian rheostat drives proton electrochemical gradients to optimize cell-type-specific growth in Arabidopsis

Brain-wide mapping of oligodendrocyte organization, oligodendrogenesis, and myelin injury

Tuning the sensitivity of mechanosensory receptors through histidine scanning

Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature

Implanted flexible electronics reveal principles of human islet cell electrical maturation | Science

$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance

J&J pours $1B into new cell therapy site in Pennsylvania

T cells store lipids and die in rheumatoid arthritis joints

Giant DNA viruses encode a hallmark translation initiation complex of eukaryotic life

Cell cycle-dependent cues regulate temporal patterning of the Drosophila central brain neural stem cells

Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering

Extracellular matrix sensing regulates intratumoral heterogeneity of autophagic flux

A single-cell time-series atlas of endothelial cell embryonic development